Evidence map›Paper›PMID 40805151›Full record

ArticleCancers2025

Evaluating Therapeutic Efficacy of Intravesical Xenogeneic Urothelial Cell Treatment Alone and in Combination with Chemotherapy or Immune Checkpoint Inhibition in a Mouse Non-Muscle-Invasive Bladder Cancer Model.

Chih-Rong Shyr, Ching-Feng Wu, Kai-Cheng Yang, Wen-Lung Ma, Chi-Ping Huang

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chih-Rong ShyrDepartment of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 404, Taiwan.
Ching-Feng WuDepartment of Medicine, Urology Division, China Medical University and Hospital, Taichung 404, Taiwan.
Kai-Cheng YangDepartment of Medicine, Urology Division, China Medical University and Hospital, Taichung 404, Taiwan.
Wen-Lung MaGraduate Institute of Biomedical Sciences, Ph.D. Program for Health Science and Industry, School of Medicine, China Medical University, Taichung 404, Taiwan.ORCID 0009-0002-7116-4304
Chi-Ping HuangDepartment of Medicine, Urology Division, China Medical University and Hospital, Taichung 404, Taiwan.

Funding

China Medical University Hospital DMR-114-030.National Science and Technology Council MOST 110-2314-B-039-026-MY3
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antitumor immunityintravesicalnon-muscle-invasive bladder cancerrejectionxenoantigenxenogeneic urothelial cell

Identifiers

PMID40805151
PMCPMC12346157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.